UQCRC2 / Cytochrome b-c1 complex subunit 2, mitochondrial · Western blot design guide

Design a Western Blot for UQCRC2

Real validated UQCRC2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-UQCRC2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for UQCRC2: expected band ~48.4 kDa, hero antibody A07937-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable UQCRC2 Western blot protocol sheet — expected band ~48.4 kDa, antibody A07937-1, controls and PMC citations. Open the full UQCRC2 WB guide →

UQCRC2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~48.4 kDa
Observed band ~48 kDa
Gel 10% (catalog A07937-1)
Positive control ⓘ Colon (IHC candidate; verify WB) +4 more
Negative control ⓘ Oral mucosa (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Acetylated
Caveat Modification-state controls
Gene-set association MSigDB Hallmark membership
Isoform 1 isoform(s)
Section 1

Real Curated UQCRC2 Western Blot Protocols

The A07937-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman HepG2, human K562, rat heart (catalog A07937-1)
Gel %10% (catalog A07937-1)
Load30 ug; reducing conditions (catalog A07937-1)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A07937-1)
Membranenitrocellulose membrane (catalog A07937-1)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A07937-1)
Primary antibodyA07937-1 · 0.1 μg/mL (catalog A07937-1)
Primary incubationovernight at 4°C (catalog A07937-1)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A07937-1)
Secondary incubation1.5 hour at RT (catalog A07937-1)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A07937-1)
DetectionECL (catalog A07937-1)
Section 2

What Is the Expected UQCRC2 Western Blot Band Size?

UQCRC2 is predicted at 48.4 kDa and observed at ~48 kDa; the cause of the small difference is not established.

What am I looking at on my blot?
Band at ~48 kDaMatches the empirical UQCRC2 band near its 48.4 kDa predicted mass
Single sharp band near 48 kDaConsistent with the one listed isoform
Faint band near 48 kDa in whole-cell lysateMay reflect the amount of mitochondrial UQCRC2 in the sample
Additional bands away from 48 kDaNot explained by the one listed isoform; verify their identity
💡Expected UQCRC2 appearanceUQCRC2 has a predicted mass of 48.4 kDa and an empirical band at ~48 kDa; confirm band identity with ordinary specificity controls.
How each factor affects band size
Predicted molecular mass48.4 kDa places the expected monomer band near the observed ~48 kDa
Lysine 66 acetylationListed modification; no visible size effect is established
Lysine 199 acetylationListed modification; no visible size effect is established
Lysine 250 acetylationListed modification; no visible size effect is established
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateMitochondrial UQCRC2 may be scarce in the sampled lysateCheck mitochondrial enrichment and include a positive-control lysate
Band higher than expectedNo listed feature establishes a higher migrating UQCRC2 bandCheck band identity with a second antibody or UQCRC2-depleted sample
Band lower than expectedNo signal peptide or propeptide cleavage is listed to explain itCompare with a positive control and verify band identity
Multiple bandsOnly one isoform is listedCheck specificity with UQCRC2 depletion and compare the ~48 kDa band
Weak or no signalMitochondrial protein abundance or recovery may be lowAssess mitochondrial recovery and include a positive-control lysate

Sample controls for UQCRC2 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for UQCRC2 in Western blot, you can use colon tissue, where HPA reports high expression.
Positive control: Colon (IHC candidate; verify WB)
Negative control: Oral mucosa (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: Mitochondrial enrichment may improve detection of this inner-membrane protein.

HPA tissue expression evidence for UQCRC2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Colon enterocytes High Protein (IHC) HPA →
Duodenum enterocytes High Protein (IHC) HPA →
Heart muscle cardiomyocytes High Protein (IHC) HPA →
Skin melanocytes High Protein (IHC) HPA →
Adipose tissue adipocytes Medium Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Oral mucosa squamous epithelial cells Not detected Protein (IHC) HPA →
Pancreas exocrine glandular cells Not detected Protein (IHC) HPA →
Appendix enterocytes Low Protein (IHC) HPA →
Epididymis glandular cells Low Protein (IHC) HPA →
Skeletal muscle myocytes Low Protein (IHC) HPA →
Section 3

Advanced UQCRC2 Western Blot Tips

Deeper troubleshooting and optimisation questions for UQCRC2, answered from its protein features.

How should UQCRC2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could UQCRC2 isoforms explain multiple bands?
Isoforms · The supplied record lists one isoform and no alternative sequence, so it does not support assigning additional bands to UQCRC2 isoforms.
Could acetylation change UQCRC2 migration?
PTM · UniProt lists N6-acetyllysine at positions 66, 199, and 250, numbered against the supplied UniProt sequence. These sites alone do not establish a visible band shift; compare treated and control samples before attributing a migration difference to acetylation.

The supplied record lists no glycosylation sites. It therefore provides no basis for assigning an unexpected band to a glycosylated UQCRC2 form. Check band identity before interpreting it as UQCRC2.
Does this guide establish induction of UQCRC2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for UQCRC2?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A07937-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should UQCRC2 be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Does the observed UQCRC2 band match its predicted mass?
Interpretation · Yes. The observed band is approximately 48 kDa, close to the predicted 48.4 kDa. The supplied features do not establish a modification-related shift.

UQCRC2 is a peripheral protein on the matrix side of the mitochondrial inner membrane. Comparing mitochondrial and other fractions can help assess whether a candidate band follows its reported location, though enrichment alone does not establish identity.

Compare equivalent mitochondrial preparations and quantify bands within the assay’s linear signal range. UQCRC2 is a component of the 11-subunit complex III, so a change in its band alone does not establish a change in the entire complex.
Boster reagents

UQCRC2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of UQCRC2 using anti-UQCRC2 antibody (A07937-1). Electrophoresis was performed on a 10% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human HepG2 whole cell lysates, Lane 2: human K562 whole cell lysates, Lane 3: rat heart tissue lysates, Lane 4: rat kidney tissue lysates, Lane 5: mouse heart tissue lysates, Lane 6: mouse kidney tissue lysates, Lane 7: mouse colon tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-UQCRC2 antigen affinity purified polyclonal antibody (A07937-1) at 0.1 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for UQCRC2 at approximately 48 kDa. The expected band size for UQCRC2 is at 48 kDa.
Anti-UQCRC2 Antibody Picoband®
Cat # A07937-1
Real WB data Western blot analysis of UQCRC2 using anti-UQCRC2 antibody (M07937). Electrophoresis was performed on a 10% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human 293T whole cell lysates, Lane 2: human HepG2 whole cell lysates, Lane 3: human K562 whole cell lysates, Lane 4: human Hacat whole cell lysates, Lane 5: rat Kidney tissue lysates, Lane 6: rat brain tissue lysates, Lane 7: mouse kidney tissue lysates, Lane 8: mouse brain tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-UQCRC2 antigen affinity purified monoclonal antibody (M07937) at 1:500 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for UQCRC2 at approximately 48 kDa. The expected band size for UQCRC2 is at 48 kDa.
Anti-UQCRC2 Monoclonal Antibody
Cat # M07937

The catalog reports two anti-UQCRC2 antibodies for Western blot: A07937-1 (polyclonal) and M07937 (monoclonal). Both list human, mouse and rat reactivity and show an approximately 48 kDa band in the captioned lysates. Evidence is limited to those reported blots.

Which to pick: Both have WB images. Choose A07937-1 for the reported heart or colon samples; choose M07937 for the reported brain or 293T samples. Both include kidney and human cell lysates. Match the published sample and antibody dilution to your experiment.

Source: BosterBio UQCRC2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.